X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ALEMBIC PHARMA FDC LTD./
ALEMBIC PHARMA
 
P/E (TTM) x 18.3 18.0 101.4% View Chart
P/BV x 3.7 4.6 80.1% View Chart
Dividend Yield % 1.3 0.7 174.1%  

Financials

 FDC LTD.   ALEMBIC PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ALEMBIC PHARMA
Mar-18
FDC LTD./
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs144645 22.2%   
Low Rs79470 16.8%   
Sales per share (Unadj.) Rs47.6166.1 28.6%  
Earnings per share (Unadj.) Rs7.621.9 34.7%  
Cash flow per share (Unadj.) Rs9.027.5 32.8%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Dividend yield (eoy) %2.00.7 281.9%  
Book value per share (Unadj.) Rs47.5117.8 40.4%  
Shares outstanding (eoy) m177.83188.52 94.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.4 69.7%   
Avg P/E ratio x14.625.5 57.4%  
P/CF ratio (eoy) x12.320.3 60.9%  
Price / Book Value ratio x2.34.7 49.4%  
Dividend payout %29.618.3 161.9%   
Avg Mkt Cap Rs m19,784105,090 18.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2216,228 19.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45931,308 27.0%  
Other income Rs m39470 559.8%   
Total revenues Rs m8,85231,378 28.2%   
Gross profit Rs m2,0706,431 32.2%  
Depreciation Rs m2491,055 23.6%   
Interest Rs m3134 91.2%   
Profit before tax Rs m2,1845,413 40.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-225-81 278.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,204 50.3%   
Profit after tax Rs m1,3534,128 32.8%  
Gross profit margin %24.520.5 119.2%  
Effective tax rate %27.722.2 124.7%   
Net profit margin %16.013.2 121.3%  
BALANCE SHEET DATA
Current assets Rs m4,35518,247 23.9%   
Current liabilities Rs m1,79211,235 15.9%   
Net working cap to sales %30.322.4 135.3%  
Current ratio x2.41.6 149.6%  
Inventory Days Days4486 51.9%  
Debtors Days Days2561 40.2%  
Net fixed assets Rs m3,02520,035 15.1%   
Share capital Rs m179377 47.4%   
"Free" reserves Rs m8,24321,824 37.8%   
Net worth Rs m8,45322,201 38.1%   
Long term debt Rs m115,000 0.2%   
Total assets Rs m10,55739,411 26.8%  
Interest coverage x71.4160.2 44.6%   
Debt to equity ratio x00.2 0.6%  
Sales to assets ratio x0.80.8 100.9%   
Return on assets %13.110.6 124.1%  
Return on equity %16.018.6 86.1%  
Return on capital %23.519.7 119.2%  
Exports to sales %13.346.4 28.7%   
Imports to sales %3.310.5 31.8%   
Exports (fob) Rs m1,12614,535 7.7%   
Imports (cif) Rs m2833,288 8.6%   
Fx inflow Rs m1,14614,722 7.8%   
Fx outflow Rs m3557,026 5.1%   
Net fx Rs m7917,696 10.3%   
CASH FLOW
From Operations Rs m1,4853,124 47.5%  
From Investments Rs m-620-8,844 7.0%  
From Financial Activity Rs m-7535,026 -15.0%  
Net Cashflow Rs m113-693 -16.3%  

Share Holding

Indian Promoters % 68.9 74.1 93.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 2.9 162.1%  
FIIs % 7.5 9.1 82.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 13.9 136.7%  
Shareholders   23,730 49,328 48.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Fall Amid Global Selloff; Sensex Down Over 400 Points(12:30 pm)

Share markets in India are presently trading on a negative note. Barring oil & gas sector, all sectoral indices are trading in red with realty stocks.

Related Views on News

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Mar 25, 2019 03:37 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS